Debopam Das

Off-label Clinical Applications of Olanzapine: A Narrative Review of Mechanisms, Efficacy and Safety

Debopam Das, Dibyajyoti Saikia & Indrani Devi Sarma · International Neuropsychiatric Disease Journal · 2026

Introduction: Off-label prescribing refers to the use of approved medications for indications, populations, dosages, or routes not formally approved by regulatory authorities. While legally permitted and often necessary in clinical practice, such use requires careful evaluation o...